| abstract |
The present invention relates to new compounds of the general formula (I), their stereoisomers, regioisomers, tautomeric forms and new intermediary compounds that are involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of new compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, pharmaceutically acceptable substrates, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and new intermediary compounds involved in synthesis |